Despite many case reports showing a rapid response and decline in Met-Hb levels following initial treatment with methylene blue, this case shows the potential for treatment-resistant and refractory methemoglobinemia, highlighting the variable response to standard treatment with methylene blue in some patients. Here, GSTM1 is linked to methemoglobinemia.